HEMODYNAMIC-EFFECTS OF HIGH-FREQUENCY OSCILLATORY VENTILATION IN SEVERE PEDIATRIC RESPIRATORY-FAILURE

Citation
Ja. Gutierrez et al., HEMODYNAMIC-EFFECTS OF HIGH-FREQUENCY OSCILLATORY VENTILATION IN SEVERE PEDIATRIC RESPIRATORY-FAILURE, Intensive care medicine, 21(6), 1995, pp. 505-510
Citations number
20
Categorie Soggetti
Emergency Medicine & Critical Care
Journal title
ISSN journal
03424642
Volume
21
Issue
6
Year of publication
1995
Pages
505 - 510
Database
ISI
SICI code
0342-4642(1995)21:6<505:HOHOVI>2.0.ZU;2-9
Abstract
Objective: To assess the hemodynamic effects of high mean proximal air way pressures (Paw) during high-frequency oscillatory ventilation (HFO V) in non-neonatal pediatrics patients with severe respiratory failure . Design: Prospective and retrospective study. Setting: Pediatric ICU in a university-affiliated hospital. Patients: 8 non-neonatal pediatri c patients with severe respiratory failure ventilated with HFOV at our institution between July 1991 and February 1994. All patients had a p ulmonary artery catheter. Interventions: HFOV. Measurements and result s: Higher Paw was required during HFOV to obtain adequate lung expansi on during the first 24 h (median 20.9 cmH(2)O, range 16.9-30.0 cmH(2)O in CMV, versus median 30.0 cmH(2)O, range 21.0-33.0 cmH(2)O in HFOV, p = 0.008), resulting in improved oxygenation as evaluated by alveolar -arterial oxygen difference (median of 557.2 mmHg, range 360.4 - 607.8 mmHg in CMV, versus median of 410.5 mmHg, range 282.9 - 550.2 mmHg af ter 24 h of HFOV, p = 0.03). The only observed effect on the cardiovas cular system was a decrease in heart rate (median of 162, range 129 - 178 in CMV, versus median of 142, range 104-195 after 24 h of HFOV, p = 0.03). Oxygen delivery, cardiac index, mean systemic arterial blood pressure, and pulmonary and systemic vascular resistances did not chan ge significantly before and after HFOV in the patients as a group, alt hough in one case a decrease in cardiac index and oxygen delivery was observed. Conclusions: High-Paw HFOV must be used cautiously, but seem s to have no discernible adverse effects on the cardiovascular system in most patients.